Alpha‐ 1‐antitrypsin phenotypes and associated disease patterns in neurological patients

Acta Neurologica Scandinavica

Volumn 91, Issue 5, 1995, Pages 394-398

  Lolin, Y I ^a   Ward, A M ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

alpha 1 antitrypsin phenotypes; multiple sclerosis; vascular disease

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; VASCULAR DISEASE;

ADULT; AGED; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CEREBROVASCULAR DISORDERS; EPILEPSY, TONIC-CLONIC; FEMALE; GENE FREQUENCY; HUMAN; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; NEOPLASMS; NERVOUS SYSTEM DISEASES; PHENOTYPE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0028901431     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1995.tb07027.x     Document Type: Article

References (28)

1. 1‐antitrypsin deficiency
2. 1‐antitrypsin deficiency: a previously unrecognized inherited disorder
3. 1 antitrypsin
4. 1‐antitrypsin deficiency
5. Pulmonary disease in alpha‐l‐antitrypsin deficiency
6. 1‐antitrypsin deficiency
7. 1‐antitrypsin deficiency
8. Alpha‐1 antitrypsin deficiency and systemic necrotizing vasculitis
9. 1 antitrypsin) in the regulation of immunologic and inflammatory reactions
10. Chromosome 14 markers in rheumatoid arthritis
11. 1‐antitrypsin deficiency
12. 3
13. 1‐antitrypsin phenotypes in patients with abdominal aortic aneurysms
14. Liver disease and heterozygous α‐1‐antitrypsin deficiency
15. 1‐antitrypsin in dried blood spots from 39289 newborns
16. 1‐antitrypsin: a health risk
17. 1 Antitrypsin (PI) phenotypes in two rheumatic diseases: A reappraisal of the association of PI subtypes in rheumatoid arthritis
18. 1‐antitrypsin
19. Proteinase inhibitors in cerebrospinal fluid in multiple sclerosis
20. On the inheritance of abdominal aortic aneurysm
21. Evaluation of factors predisposing to arterial thrombosis in coronary artery disease
22. Serine protease inhibitors (serpins)
23. Acid proteinase activity of white matter and plaques in multiple sclerosis
24. Leucocyte proteinase activity and acute multiple sclerosis
25. Rheological and fibrinolytic findings in multiple sclerosis
26. Measles antibodies, anti‐proteinase and plasminogen distribution in serum and plasma from patients affected with multiple sclerosis and patients affected with non‐neurological diseases
27. 2 macroglobulin
28. α‐1‐antitrypsin (Pi) types in multiple sclerosis and lack of interaction with immunoglobulin (Gm) markers